Stay updated on Flotetuzumab in Relapsed AML/MDS Post Allo-HCT Clinical Trial

Sign up to get notified when there's something new on the Flotetuzumab in Relapsed AML/MDS Post Allo-HCT Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Flotetuzumab in Relapsed AML/MDS Post Allo-HCT Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Recruitment is now closed in the study history, indicating no further participants are being sought. A new revision entry (v3.6.0) was added and the prior revision (v3.5.5) was removed, updating the record version.
    Difference
    0.5%
    Check dated 2026-06-15T05:32:24.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    A new revision entry labeled v3.5.5 has been added to the study record history. The previous revision v3.5.4 has been removed from the history.
    Difference
    0.1%
    Check dated 2026-06-08T04:20:46.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The page history now shows a new revision label v3.5.4, replacing the previous v3.5.3. This reflects a new build of the page history rather than changes to the study data or text.
    Difference
    0.1%
    Check dated 2026-05-17T09:59:27.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The page’s interface/version indicator was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a site release rather than any change to the underlying study or its details.
    Difference
    0.1%
    Check dated 2026-04-24T22:40:14.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    - Added Revision: v3.5.2. - Deleted Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T14:15:27.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    Added revision: v3.5.0 and removed revision: v3.4.3 from the version history.
    Difference
    0.1%
    Check dated 2026-03-19T23:41:37.000Z thumbnail image

Stay in the know with updates to Flotetuzumab in Relapsed AML/MDS Post Allo-HCT Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Flotetuzumab in Relapsed AML/MDS Post Allo-HCT Clinical Trial page.